R. Foley, P. Parfrey, and M. Sarnak, Clinical epidemiology of cardiovascular disease in chronic renal disease, American Journal of Kidney Diseases, vol.32, issue.5, pp.112-121, 1998.
DOI : 10.1053/ajkd.1998.v32.pm9820470

R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke et al., Chronic kidney disease as cause of cardiovascular morbidity and mortality, Nephrology Dialysis Transplantation, vol.20, issue.6, pp.1048-56, 2005.
DOI : 10.1046/j.1523-1755.2003.00924.x

G. Manjunath, H. Tighiouart, J. Coresh, B. Macleod, D. Salem et al., Level of kidney function as a risk factor for cardiovascular outcomes in the elderly, Kidney International, vol.63, issue.3, pp.1121-1130, 2003.
DOI : 10.1046/j.1523-1755.2003.00838.x

G. Oniscu, H. Brown, and J. Forsythe, Impact of Cadaveric Renal Transplantation on Survival in Patients Listed for Transplantation, Journal of the American Society of Nephrology, vol.16, issue.6, pp.1859-65, 2005.
DOI : 10.1681/ASN.2004121092

A. Ojo, J. Hanson, R. Wolfe, A. Leichtman, L. Agodoa et al., Long-term survival in renal transplant recipients with graft function, Kidney International, vol.57, issue.1, 2000.
DOI : 10.1046/j.1523-1755.2000.00816.x

S. Bayat, M. Kessler, S. Briançon, and L. Frimat, Survival of transplanted and dialysed patients in a French region with focus on outcomes in the elderly, Nephrology Dialysis Transplantation, vol.22, issue.2, pp.292-300, 2010.
DOI : 10.1093/ndt/gfl637

URL : https://hal.archives-ouvertes.fr/hal-00748834

B. Culleton, M. Larson, J. Evans, P. Wilson, B. Barrett et al., Prevalence and Correlates of Elevated Serum Creatinine Levels, Archives of Internal Medicine, vol.159, issue.15, pp.1785-90, 1999.
DOI : 10.1001/archinte.159.15.1785

P. Zager, J. Nikolic, R. Brown, M. Campbell, W. Hunt et al., ???U??? curve association of blood pressure and mortality in hemodialysis patients, Kidney International, vol.54, issue.2, pp.561-570, 1998.
DOI : 10.1046/j.1523-1755.1998.00005.x

B. Astor, P. Muntner, A. Levin, J. Eustace, and J. Coresh, Association of Kidney Function With Anemia, Archives of Internal Medicine, vol.162, issue.12, pp.1401-1409, 2002.
DOI : 10.1001/archinte.162.12.1401

A. Walker, G. Schneider, J. Yeaw, B. Nordstrom, S. Robbins et al., Anemia as a Predictor of Cardiovascular Events in Patients with Elevated Serum Creatinine, Journal of the American Society of Nephrology, vol.17, issue.8, pp.2293-2301, 2006.
DOI : 10.1681/ASN.2005020183

A. Phromminintkul, S. Haas, M. Elsik, and H. Krum, Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis, The Lancet, vol.369, issue.9559, pp.381-389, 2007.
DOI : 10.1016/S0140-6736(07)60194-9

R. Parekh, L. Plantinga, and W. Kao, The association of sudden cardiac death with inflammation and other traditional risk factors, Kidney International, vol.74, issue.10, pp.1335-1377, 2008.
DOI : 10.1038/ki.2008.449

C. Wanner and T. Metzger, C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients, Nephrology Dialysis Transplantation, vol.17, issue.90008, pp.29-32, 2002.
DOI : 10.1093/ndt/17.suppl_8.29

M. Shishehbor, L. Oliveira, and M. Lauer, Emerging Cardiovascular Risk Factors That Account for a Significant Portion of Attributable Mortality Risk in Chronic Kidney Disease, The American Journal of Cardiology, vol.101, issue.12, pp.1741-1747, 2008.
DOI : 10.1016/j.amjcard.2008.02.060

Q. Yang, L. Botto, and J. Erickson, Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002, Circulation, vol.113, issue.10, pp.1335-1378, 1990.
DOI : 10.1161/CIRCULATIONAHA.105.570846

P. Mccullough, V. Agrawal, E. Danielewcz, and G. Abela, Accelerated Atherosclerotic Calcification and Monckeberg's Sclerosis: A Continuum of Advanced Vascular Pathology in Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.3, issue.6, pp.1585-98, 2008.
DOI : 10.2215/CJN.01930408

G. Block, T. Hulbert-shearon, N. Levin, and F. Port, Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study, American Journal of Kidney Diseases, vol.31, issue.4, pp.607-624, 1998.
DOI : 10.1053/ajkd.1998.v31.pm9531176

S. Zieman, V. Melenovsky, and K. Da, Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.5, pp.932-943, 2005.
DOI : 10.1161/01.ATV.0000160548.78317.29

J. Millar, A. Lever, and V. Burke, Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial, Journal of Hypertension, vol.17, issue.8, pp.1065-72, 1999.
DOI : 10.1097/00004872-199917080-00004

M. Safar and . Lg, The arterial system in human hypertension. Text book of hypertension, 1994.

G. London, A. Guerin, B. Pannier, S. Marchais, A. Benetos et al., Incresaed systolic pressure in chronic uremia. Role of arterial wave reflections, Hypertension, 1992.

A. Pauca, S. Wallenhaupt, N. Kon, and W. Tucker, Does radial artery pressure accurately reflect aortic pressure? Chest, pp.1193-1201, 1992.
DOI : 10.1378/chest.102.4.1193

J. Bramwell and . Ha, The Velocity of the Pulse Wave in Man, Proceedings of the Royal Society B: Biological Sciences, vol.93, issue.652, pp.298-306, 1922.
DOI : 10.1098/rspb.1922.0022

N. Wimmer, R. Townsend, M. Joffe, J. Lash, and A. Go, Chronic Renal Insuffciency Cohort Study Investigators. Correlation between pulse wave velocity and other measures of arterial stiffness in chronic kidney disease, Clin Nephrol, vol.68, issue.3, pp.133-176, 2007.

A. Khoshdel, S. Carney, B. Nair, and A. Gillies, Better Management of Cardiovascular Diseases by Pulse Wave Velocity: Combining Clinical Practice with Clinical Research using Evidence-Based Medicine, Clinical Medicine & Research, vol.5, issue.1, pp.45-52, 2007.
DOI : 10.3121/cmr.2007.708

A. Guerin, B. Pannier, S. Marchais, and G. London, Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders, Current Opinion in Nephrology and Hypertension, vol.15, issue.2, pp.105-110, 2006.
DOI : 10.1097/01.mnh.0000203186.11772.21

S. Laurent, P. Boutouyrie, R. Asmar, I. Gautier, B. Laloux et al., Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients, Hypertension, vol.37, issue.5, pp.1236-1277, 2001.
DOI : 10.1161/01.HYP.37.5.1236

R. Asmar, A. Benetos, J. Topouchian, S. Laurent, B. Pannier et al., Assessment of Arterial Distensibility by Automatic Pulse Wave Velocity Measurement : Validation and Clinical Application Studies, Hypertension, vol.26, issue.3, pp.485-90, 1995.
DOI : 10.1161/01.HYP.26.3.485

P. Salvi, G. Lio, C. Labat, E. Ricci, B. Pannier et al., Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity, Journal of Hypertension, vol.22, issue.12, pp.2285-2294, 2004.
DOI : 10.1097/00004872-200412000-00010

R. Asmar, Noninvasive evaluation of arterial abnormalities in hypertensive patients, Pathol Biol, vol.47, issue.7, pp.685-95, 1999.

G. London, A. Guerin, B. Pannier, S. Marchais, and M. Stimpel, Influence of Sex on Arterial Hemodynamics and Blood Pressure : Role of Body Height, Hypertension, vol.26, issue.3, 1995.
DOI : 10.1161/01.HYP.26.3.514

G. London, S. Marchais, A. Guerin, and B. Pannier, Arterial Stiffness: pathophysiologie and clinical impact. Clin and Exp Hypert, pp.689-699, 2004.

J. Blacher, A. Guerin, B. Pannier, S. Marchais, and G. London, Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease, Hypertension, vol.38, issue.4, pp.938-980, 2001.
DOI : 10.1161/hy1001.096358

P. Raggi, A. Bellasi, E. Ferramosca, T. Islam, P. Muntner et al., Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients, Kidney International, vol.71, issue.8, pp.802-809, 2007.
DOI : 10.1038/sj.ki.5002164

M. Temmar, S. Renard, C. Czernichow, S. Esper, N. Shahapuni et al., Pulse wave velocity and vascular calcification at different stages of chronic kidney disease, Journal of Hypertension, vol.28, issue.1, pp.163-172, 2010.
DOI : 10.1097/HJH.0b013e328331b81e

J. Blacher, A. Guerin, B. Pannier, S. Marchais, M. Safar et al., Impact of Aortic Stiffness on Survival in End-Stage Renal Disease, Circulation, vol.99, issue.18, pp.2434-2443, 1999.
DOI : 10.1161/01.CIR.99.18.2434

M. Ketteler and P. Biggar, Review article: Getting the balance right: Assessing causes and extent of vascular calcification in chronic kidney disease, Nephrology, vol.19, issue.4, 2009.
DOI : 10.1172/JCI17202

H. Stary, Natural history of calcium deposits in atherosclerosis progression and regression, Zeitschrift f???r Kardiologie, vol.89, issue.14, pp.28-35, 2000.
DOI : 10.1007/s003920070097

P. Raggi, A. Boulay, S. Chasan-taber, N. Amin, M. Dillon et al., Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?, ACC Current Journal Review, vol.11, issue.4, pp.695-701, 2002.
DOI : 10.1016/S1062-1458(02)00700-6

A. Zelinger, R. Wahs, T. Graboys, and M. Tavel, Asymptomatic Coronary Artery Disease, Chest, vol.121, issue.5, pp.1684-1691, 2002.
DOI : 10.1378/chest.121.5.1684

S. Moe, O. Neill, K. Reslerova, M. Fineberg, N. Persohn et al., Natural history of vascular calcification in dialysis and transplant patients, Nephrology Dialysis Transplantation, vol.43, issue.2, pp.2387-93, 2004.
DOI : 10.1053/j.ajkd.2003.10.035

S. Letho, L. Niskanen, M. Suhonen, T. Rnnemaa, and M. Laakso, Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulindependent mellitus: Arterioscler Thromb Vasc Biol, pp.978-83, 1996.

P. Greenland, B. Ro, B. Brundage, M. Budoff, M. Eisenberg et al., ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain, Journal of the American College of Cardiology, vol.49, issue.3, pp.402-428, 2007.
DOI : 10.1016/j.jacc.2006.10.001

G. London, S. Marchais, A. Guérin, and F. Métivier, Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia, Current Opinion in Nephrology and Hypertension, vol.14, issue.6, pp.525-556, 2005.
DOI : 10.1097/01.mnh.0000168336.67499.c0

K. Bostrom, K. Watson, S. Horn, C. Wortham, I. Herman et al., Bone morphogenetic protein expression in human atherosclerotic lesions., Journal of Clinical Investigation, vol.91, issue.4, pp.1800-1809, 1993.
DOI : 10.1172/JCI116391

G. London, A. Guerin, S. Marchais, F. Métivier, B. Pannier et al., Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality, Nephrology Dialysis Transplantation, vol.18, issue.9, pp.1731-1771, 2003.
DOI : 10.1093/ndt/gfg414

S. Moe, T. Drueke, J. Cunningham, W. Goodman, K. Olgaard et al., Definition, evaluation, and classification of renal osteodystrophie: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int, pp.1945-53, 2006.

K. Kalantar-zadeh, N. Kuwae, D. Redigor, C. Kovesdy, R. Kilpatrick et al., Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients, Kidney International, vol.70, issue.4
DOI : 10.1038/sj.ki.5001514

A. Guerin, G. London, S. Marchais, and F. Metivier, Arterial stiffening and vascular calcifications in end???stage renal disease, Nephrology Dialysis Transplantation, vol.15, issue.7, 2000.
DOI : 10.1093/ndt/15.7.1014

A. Cardus, E. Parisi, C. Gallego, M. Aldea, E. Fernandez et al., 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway, Kidney International, vol.69, issue.8, pp.1377-84, 2006.
DOI : 10.1038/sj.ki.5000304

F. Tentori, W. Hunt, C. Stidley, M. Rohrscheib, E. Bedrick et al., Mortality risk among hemodialysis patients receiving different vitamin D analogs, Kidney International, vol.70, issue.10, pp.1858-1865, 2006.
DOI : 10.1038/sj.ki.5001868

M. Cozzolino, D. Brancaccio, M. Gallieni, and E. Slatopolsky, Pathogenesis of vascular calcification in chronic kidney disease, Kidney Int, p.195, 2006.

C. Schafer, A. Heiss, A. Schwarz, R. Westenfeld, M. Ketteler et al., The serum protein ??2???Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification, Journal of Clinical Investigation, vol.112, issue.3, pp.357-66, 2003.
DOI : 10.1172/JCI17202

S. Moe, M. Reslerova, M. Ketteler, O. , K. Duan et al., Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD) Kidney Int, 2005.

E. Cranenburg, C. Vermeer, R. Koos, M. Boumans, T. Hackeng et al., The Circulating Inactive Form of Matrix Gla Protein (ucMGP) as a Biomarker for Cardiovascular Calcification, Journal of Vascular Research, vol.45, issue.5
DOI : 10.1159/000124863

S. Moe, D. Duan, B. Doehle, O. Neil, K. Chen et al., Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels, Kidney International, vol.63, issue.3, pp.1003-1014, 2003.
DOI : 10.1046/j.1523-1755.2003.00820.x

S. Moe, Uremic vasculopathy, Seminars in Nephrology, vol.24, issue.5, pp.413-419, 2004.
DOI : 10.1016/j.semnephrol.2004.06.015

M. Schoppet, K. Preissner, and L. Hofbauer, RANK Ligand and Osteoprotegerin: Paracrine Regulators of Bone Metabolism and Vascular Function, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.4, pp.549-53, 2002.
DOI : 10.1161/01.ATV.0000012303.37971.DA

J. Emery, P. Mcdonnell, M. Burke, K. Deen, S. Lyn et al., Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL, Journal of Biological Chemistry, vol.158, issue.23, pp.14363-14370, 1998.
DOI : 10.1016/0092-8674(93)80065-M

. Osteo, chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification, Arterioscler Thromb Vasc Biol, vol.23, issue.3, pp.489-94, 2003.

M. Whyte, S. Obrecht, P. Finnegan, J. Jones, M. Podgornik et al., Osteoprotegerin deficiency and juvenile Paget " s disease, N Engl J Med
DOI : 10.1056/nejmoa013096

S. Kiechl, G. Schett, G. Wenning, K. Redlich, M. Oberhollenzer et al., Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation, pp.2175-80, 2004.

S. Doi, N. Yorioka, T. Masaki, T. Ito, K. Shigemoto et al., Incresaed serum osteoprotegerin level in older and diabetic hemodialysis patients. Ther Apher Dial, pp.335-344, 2004.

J. Kazama, T. Shigematsu, K. Yano, E. Tsuda, M. Miura et al., Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure, American Journal of Kidney Diseases, vol.39, issue.3, pp.525-557, 2002.
DOI : 10.1053/ajkd.2002.31402

G. Jean, E. Bresson, J. Terrat, J. Vanel, J. Hurrot et al., Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences, Nephrology Dialysis Transplantation, vol.18, issue.4, pp.948-55, 2009.
DOI : 10.1111/j.1525-139X.2005.18407.x

R. Shroff, V. Shah, M. Hiorns, M. Schoppet, L. Hofbauer et al., The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis, Nephrology Dialysis Transplantation, vol.90, issue.5, pp.3263-71, 2008.
DOI : 10.1083/jcb.200402046

K. Nitta, T. Akiba, K. Uchida, S. Otsubo, T. Takei et al., Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients, Nephrology Dialysis Transplantation, vol.55, issue.2, pp.1886-1895, 2004.
DOI : 10.1046/j.1523-1755.1999.00273.x

M. Morena, N. Terrier, I. Jaussent, H. Leray-moragues, L. Chalabi et al., Plasma Osteoprotegerin Is Associated with Mortality in Hemodialysis Patients, Journal of the American Society of Nephrology, vol.17, issue.1, 2006.
DOI : 10.1681/ASN.2005030260

URL : https://hal.archives-ouvertes.fr/inserm-00085024

D. Goldsmith, E. Ritz, and A. Covic, Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int, 2004.

A. Agatston, W. Janowitz, F. Hildner, N. Zusmer, M. Viamonte et al., Quantification of coronary artery calcium using ultrafast computed tomography, Journal of the American College of Cardiology, vol.15, issue.4, pp.827-859, 1990.
DOI : 10.1016/0735-1097(90)90282-T

S. Hanada, R. Ando, S. Naito, N. Kobayashi, M. Wakabayashi et al., Assessment and significance of abdominal aortic calcification in chronic kidney disease, Nephrology Dialysis Transplantation, vol.26, issue.5, pp.1888-95, 2010.
DOI : 10.1159/000095782

M. Nasrallah, A. El-shehaby, M. Salem, N. Osman, and E. Sheikh, Sharaf El Din UA: Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients, Nephrol Dial Transplant, 2010.

A. Go, G. Chertow, D. Fan, C. Mcculloch, and C. Hsu, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 2004.

H. Pilmore, H. Dent, S. Chang, M. Donald, S. Chadban et al., Reduction in Cardiovascular Death After Kidney Transplantation, Transplantation, vol.89, issue.7, pp.851-858, 2010.
DOI : 10.1097/TP.0b013e3181caeead

H. Meier-kriesche, R. Baliga, and B. Kaplan, Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation, Transplantation, 2003.

Y. Vanrenterghem, K. Claes, G. Montagnino, S. Fieuws, B. Maes et al., Risk Factors for Cardiovascular Events After Successful Renal Transplantation, Transplantation, vol.85, issue.2, pp.209-225, 2008.
DOI : 10.1097/TP.0b013e318160254f

G. Opelz, M. Zeier, G. Laux, C. Morath, and B. Döhler, No Improvement of Patient or Graft Survival in Transplant Recipients Treated with Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers: A Collaborative Transplant Study Report, Journal of the American Society of Nephrology, vol.17, issue.11, pp.3257-62, 2006.
DOI : 10.1681/ASN.2006050543

M. Tokmakova, H. Skali, S. Kenchaiah, E. Braunwald, J. Rouleau et al., Chronic Kidney Disease, Cardiovascular Risk, and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction: The Survival And Ventricular Enlargement (SAVE) Study, Circulation, vol.110, issue.24, pp.3667-73, 2004.
DOI : 10.1161/01.CIR.0000149806.01354.BF

H. Meier-kriesche, J. Arndorfer, and B. Kaplan, THE IMPACT OF BODY MASS INDEX ON RENAL TRANSPLANT OUTCOMES, Transplantation, vol.73, issue.1, pp.70-74, 2002.
DOI : 10.1097/00007890-200201150-00013

P. Stenvinkel, O. Heimbürger, F. Paultre, U. Diczfalusy, T. Wang et al., Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure, Kidney International, vol.55, issue.5, pp.1899-911, 1999.
DOI : 10.1046/j.1523-1755.1999.00422.x

B. Kasiske, C. Guijarro, Z. Massy, M. Wiederkehr, and J. Ma, Cardiovascular disease after renal transplantation, J Am Soc Nephrol, vol.7, issue.1, pp.158-65, 1996.

H. Holdaas, B. Fellström, A. Jardine, I. Holme, G. Nyberg et al., Assessment of Lescol in Renal Transplantation (ALERT) Study Investigators: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomized, placebocontrolled trial: Lancet, pp.2024-2055, 2003.

M. Molnar, M. Czira, C. Ambrus, L. Szeifert, A. Szentkiralyi et al., Anemia is associated with mortality in kidneytransplanted patients-a prospective cohort study, Am J Transplant, 2007.

H. Meier-kriesche and B. Kaplan, Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes, Transplantation, vol.74, issue.10
DOI : 10.1097/00007890-200211270-00005

J. Pascual, J. Van-hooff, K. Salmela, P. Lang, P. Rigotti et al., Three-year observational follow-up of a multicnter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. Transplantation, pp.55-61, 2006.

G. Opelz, B. Döhler, and G. Laux, Long-Term Prospective Study of Steroid Withdrawal in Kidney and Heart Transplant Recipients, American Journal of Transplantation, vol.11, issue.4, pp.720-728, 2005.
DOI : 10.1016/S0041-1345(96)00013-9

B. Kasiske, J. Snyder, D. Gilbertson, and A. Matas, Diabetes Mellitus after Kidney Transplantation in the United States, American Journal of Transplantation, vol.72, issue.6, pp.178-85, 2003.
DOI : 10.1097/00007890-200109270-00015

S. Bunnapradist, A. Daswani, and S. Takemoto, GRAFT SURVIVAL FOLLOWING LIVING-DONOR RENAL TRANSPLANTATION, Transplantation, vol.76, issue.1, pp.10-15, 2003.
DOI : 10.1097/01.TP.0000079965.62765.1A

URL : http://pdfs.journals.lww.com/transplantjournal/2003/07150/GRAFT_SURVIVAL_FOLLOWING_LIVING_DONOR_RENAL.3.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1505259340647;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdGlb2qsojlvlytk14LkMXSEQnF1+SsN25/rq+QMg9lOaO7dsv6WQb1ajs5vWCDr1y;hash|wOdna7vwlGbWuiICbBblHA==

F. Verbeke, W. Van-biesen, P. Peeters, V. Bortel, L. Vanholder et al., Arterial stiffness and wave reflections in renal transplant recipients, Nephrology Dialysis Transplantation, vol.22, issue.10, pp.3021-3028, 2007.
DOI : 10.1093/ndt/gfm379

A. Covic, D. Goldsmith, P. Gusbeth-tatomir, I. Buhaescu, and M. Covic, Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients, Transplantation, vol.76, issue.11
DOI : 10.1097/01.TP.0000086343.32903.A8

K. Keven, R. Calayoglu, S. Sengule, I. Dincer, S. Kutlay et al., Comparative effects of renal transplantation and maintenance dialysis on arterial stiffness and left ventricular mass index, Clinical Transplantation, vol.19, issue.Suppl. 3, pp.360-365, 2008.
DOI : 10.1161/01.HYP.37.6.1429

M. Kneifel, A. Scholze, A. Burkert, G. Offermann, L. Rothermund et al., Impaired Renal Allograft Function is Associated with Increased Arterial Stiffness in Renal Transplant Recipients., American Journal of Transplantation, vol.9, issue.4, pp.1624-1654, 2006.
DOI : 10.1056/NEJMoa052891

S. Bahous, A. Stephan, W. Barakat, J. Blacher, R. Asmar et al., Aortic pulse wave velocity in renal transplant patients, Kidney International, vol.66, issue.4, pp.1486-92, 2004.
DOI : 10.1111/j.1523-1755.2004.00912.x

P. Strozecki, A. Adamowicz, Z. Wlodarczyk, and J. Manitius, The Influence of Calcineurin Inhibitors on Pulse Wave Velocity in Renal Transplant Recipients, Renal Failure, vol.107, issue.6, pp.679-84, 2007.
DOI : 10.1161/01.CIR.0000065222.34933.FC

A. Martinez-castelao, X. Sarrias, O. Bestard, S. Gil-vernet, D. Seron et al., Arterial Elasticity Measurement in Renal Transplant Patients Under Anticalcineurin Immunosuppression, Transplantation Proceedings, vol.37, issue.9, 2005.
DOI : 10.1016/j.transproceed.2005.10.078

J. Seckinger, C. Sommerer, U. Hinkel, O. Hoffmann, M. Zeier et al., Switch of immunosuppression from cycvlosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients, J Hypertens, 2008.

S. Abedi, M. Tarzamni, M. Nakhjavani, and A. Bohloolo, Effect of renal transplantation on coronary artery calcification in hemodialysis patients. Transplant proc, pp.2829-2860, 2009.

S. Deloach, M. Joffe, X. Mai, S. Goral, and S. Rossa, Aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation, Nephrology Dialysis Transplantation, vol.121, issue.10, pp.1314-1323, 2009.
DOI : 10.1378/chest.121.5.1468

D. Cohen, K. Warburton, G. Warren, R. Bloom, and R. Townsend, Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients, American Journal of Hypertension, vol.17, issue.3
DOI : 10.1016/j.amjhyper.2003.11.002

G. Jean and C. Chazot, L???essentiel des nouvelles recommandations des kidney disease: improving global outcomes (KDIGO) pour les d??sordres du m??tabolisme min??ral et osseux ?? l???usage du clinicien francophone, N??phrologie & Th??rapeutique, vol.6, issue.3, pp.151-158, 2010.
DOI : 10.1016/j.nephro.2009.12.003

S. Bayat, L. Frimat, N. Thilly, C. Loos, S. Briancon et al., Medical and non-medical determinants of access to renal transplant waiting list in a French community-based network of care, Nephrology Dialysis Transplantation, vol.21, issue.10, pp.2900-2907, 2006.
DOI : 10.1093/ndt/gfi099

S. Seiler, G. Heine, and D. Filser, Clinical relevance of FGF-23 in chronic kidney disease, Kidney International, vol.76, issue.114, pp.34-42, 2009.
DOI : 10.1038/ki.2009.405

J. Stubbs, S. Liu, W. Tang, J. Zhou, Y. Wang et al., Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular camcification and mortality in fibroblastic growth factor 23 null mice, J Am Soc Nephrol, 2007.

M. Inaba, S. Okuno, Y. Imanishi, S. Yamada, A. Shioi et al., Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients, Osteoporosis International, vol.71, issue.Suppl, pp.1506-1519, 2006.
DOI : 10.1172/JCI200419081

F. Kojima, K. Uchida, T. Ogawa, Y. Tanaka, and K. Nitta, Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis, International Urology and Nephrology, vol.39, issue.4 Suppl 1, pp.1067-74, 2008.
DOI : 10.1172/JCI200419081

O. Guttierez, M. Mannstadt, T. Isakova, J. Rauh-hain, H. Tamez et al., Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis, New England Journal of Medicine, vol.359, issue.6, pp.584-92, 2008.
DOI : 10.1056/NEJMoa0706130

H. Kurosu, Y. Ogawa, M. Miyoshi, M. Yamamoto, A. Nandi et al., Regulation of Fibroblast Growth Factor-23 Signaling by Klotho, Journal of Biological Chemistry, vol.285, issue.10, pp.6120-6123, 2006.
DOI : 10.1016/j.cmet.2005.09.001

D. Friedman, M. Afkarian, H. Tamez, I. Bhan, T. Isakova et al., Klotho Variants and Chronic Hemodialysis Mortality, Journal of Bone and Mineral Research, vol.24, issue.11, 2009.
DOI : 10.1359/jbmr.090516

URL : http://onlinelibrary.wiley.com/doi/10.1359/jbmr.090516/pdf